Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2026
  • Page 7
handgrip-strength-links-physical,-cognitive-health-in-tanzanian-elders
Posted inBiotechnology

Handgrip Strength Links Physical, Cognitive Health in Tanzanian Elders

February 26, 2026
In the rapidly aging global population, understanding the interconnectedness of physical and cognitive health has become a focal point for…
Read More
correction:-sirt6-loss-in-fat-cells-hurts-fasting-adaptation
Posted inBiotechnology

Correction: Sirt6 Loss in Fat Cells Hurts Fasting Adaptation

February 26, 2026
In a groundbreaking new study published in Experimental & Molecular Medicine, researchers explore the intricate role of Sirt6, a member…
Read More
sedentary-behavior-and-power-impact-frailty-in-elderly
Posted inBiotechnology

Sedentary Behavior and Power Impact Frailty in Elderly

February 26, 2026
In the rapidly aging global population, understanding the intricate dynamics of frailty has taken center stage in geriatric research. A…
Read More
green-hydrogen-breakthrough:-sustainable-production-without-harmful-chemicals-or-iridium
Posted inBiotechnology

Green Hydrogen Breakthrough: Sustainable Production Without Harmful Chemicals or Iridium

February 26, 2026
Green hydrogen has emerged as a cornerstone for the future of clean energy, promising a carbon-neutral alternative to fossil fuels.…
Read More
new-study-reveals-why-eczema-commonly-starts-in-childhood
Posted inBiotechnology

New Study Reveals Why Eczema Commonly Starts in Childhood

February 26, 2026
In a groundbreaking study published in Nature on February 25, 2026, scientists from the Icahn School of Medicine at Mount…
Read More
bristol-myers’-$800m-adc-hits-primary-survival-endpoints-in-phase-3-breast-cancer-trial
Posted inBiotechnology

Bristol Myers’ $800M ADC hits primary survival endpoints in phase 3 breast cancer trial

February 26, 2026
A Chinese phase 3 trial of Bristol Myers Squibb’s antibody-drug conjugate has hit its dual primary survival endpoints, providing further validation…
Read More
dexmedetomidine-vs.-opioids-in-neonatal-hie-sedation
Posted inBiotechnology

Dexmedetomidine vs. Opioids in Neonatal HIE Sedation

February 26, 2026
Therapeutic hypothermia (TH) has revolutionized the management of neonates suffering from hypoxic-ischemic encephalopathy (HIE), offering a neuroprotective strategy that substantially…
Read More
protagonist-plans-to-pocket-$400m-from-takeda-rather-than-split-us-rusfertide-profits
Posted inBiotechnology

Protagonist plans to pocket $400M from Takeda rather than split US rusfertide profits

February 26, 2026
While the FDA mulls whether to approve Protagonist Therapeutics’ hematology asset, the biotech is thinking it will pocket $400 million…
Read More
osteocytic-lipocalin-2-controls-bone-formation-via-ferroptosis
Posted inBiotechnology

Osteocytic Lipocalin-2 Controls Bone Formation via Ferroptosis

February 26, 2026
In a groundbreaking study set to reshape our understanding of bone biology, researchers have uncovered a pivotal role for osteocytic…
Read More
dusp26-shields-kidneys-by-dephosphorylating-p53-s312
Posted inBiotechnology

DUSP26 Shields Kidneys by Dephosphorylating p53 S312

February 26, 2026
In a groundbreaking study published in Nature Communications, researchers have unveiled a novel molecular mechanism by which the enzyme dual-specificity…
Read More

Posts pagination

Previous page 1 … 5 6 7 8 9 … 293 Next page

Privacy Policy    Terms

Scroll to Top